A COVID-19 vaccine efficacy test created by Bucks County biotechnology firm FlowMetric got a boost of $750,000 in state funding. The capital infusion resulted from the work of state Senator Steve Santarsiero (D-10).

“If the last year and a half or so has taught us anything, it’s that having data and information is critically important,” said Sen. Santarsiero.

“I was proud to advocate for the Keystone Communities Program Grant for FlowMetric, a company that is really on the cutting-edge of doing great work, here at the PA Biotech Center. This test will not only determine vaccine efficacy of the COVID-19 vaccines available in the United States but will lead the way for future vaccine efficacy testing.”

FlowMetric CEO Renaldo Capocasale thanked Senator Santarsiero for his help in securing the grant funding.

The dollars will be used for purchasing lab equipment to expand testing capabilities and investing in mobile labs to improve access to community-based testing.

Sen. Santarsiero was the beneficiary of the science he championed. While onsite for a visit, he received test results that confirmed his own immunity, gained from a coronavirus infection. He later chose to be vaccinated.

FlowMetric operates in one of the nation’s most successful life sciences incubators, located in Buckingham Township.